Rational design of cationic lipids for siRNA delivery. 2010

Sean C Semple, and Akin Akinc, and Jianxin Chen, and Ammen P Sandhu, and Barbara L Mui, and Connie K Cho, and Dinah W Y Sah, and Derrick Stebbing, and Erin J Crosley, and Ed Yaworski, and Ismail M Hafez, and J Robert Dorkin, and June Qin, and Kieu Lam, and Kallanthottathil G Rajeev, and Kim F Wong, and Lloyd B Jeffs, and Lubomir Nechev, and Merete L Eisenhardt, and Muthusamy Jayaraman, and Mikameh Kazem, and Martin A Maier, and Masuna Srinivasulu, and Michael J Weinstein, and Qingmin Chen, and Rene Alvarez, and Scott A Barros, and Soma De, and Sandra K Klimuk, and Todd Borland, and Verbena Kosovrasti, and William L Cantley, and Ying K Tam, and Muthiah Manoharan, and Marco A Ciufolini, and Mark A Tracy, and Antonin de Fougerolles, and Ian MacLachlan, and Pieter R Cullis, and Thomas D Madden, and Michael J Hope
Tekmira Pharmaceuticals, Burnaby, British Columbia, Canada. ssemple@tekmirapharm.com

We adopted a rational approach to design cationic lipids for use in formulations to deliver small interfering RNA (siRNA). Starting with the ionizable cationic lipid 1,2-dilinoleyloxy-3-dimethylaminopropane (DLinDMA), a key lipid component of stable nucleic acid lipid particles (SNALP) as a benchmark, we used the proposed in vivo mechanism of action of ionizable cationic lipids to guide the design of DLinDMA-based lipids with superior delivery capacity. The best-performing lipid recovered after screening (DLin-KC2-DMA) was formulated and characterized in SNALP and demonstrated to have in vivo activity at siRNA doses as low as 0.01 mg/kg in rodents and 0.1 mg/kg in nonhuman primates. To our knowledge, this represents a substantial improvement over previous reports of in vivo endogenous hepatic gene silencing.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D002412 Cations Positively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis. Cation
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D034741 RNA, Small Interfering Small double-stranded, non-protein coding RNAs (21-31 nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, Dicer, that generates miRNAs (MICRORNAS). The perfect match of the siRNAs' antisense strand to their target RNAs mediates RNAi by siRNA-guided RNA cleavage. siRNAs fall into different classes including trans-acting siRNA (tasiRNA), repeat-associated RNA (rasiRNA), small-scan RNA (scnRNA), and Piwi protein-interacting RNA (piRNA) and have different specific gene silencing functions. RNA, Scan,Repeat-Associated siRNA,Scan RNA,Small Scan RNA,Trans-Acting siRNA,siRNA,siRNA, Repeat-Associated,siRNA, Trans-Acting,Short Hairpin RNA,Short Interfering RNA,Small Hairpin RNA,Small Interfering RNA,scnRNA,shRNA,tasiRNA,Hairpin RNA, Short,Hairpin RNA, Small,Interfering RNA, Short,Interfering RNA, Small,RNA, Short Hairpin,RNA, Short Interfering,RNA, Small Hairpin,RNA, Small Scan,Repeat Associated siRNA,Scan RNA, Small,Trans Acting siRNA,siRNA, Repeat Associated,siRNA, Trans Acting

Related Publications

Sean C Semple, and Akin Akinc, and Jianxin Chen, and Ammen P Sandhu, and Barbara L Mui, and Connie K Cho, and Dinah W Y Sah, and Derrick Stebbing, and Erin J Crosley, and Ed Yaworski, and Ismail M Hafez, and J Robert Dorkin, and June Qin, and Kieu Lam, and Kallanthottathil G Rajeev, and Kim F Wong, and Lloyd B Jeffs, and Lubomir Nechev, and Merete L Eisenhardt, and Muthusamy Jayaraman, and Mikameh Kazem, and Martin A Maier, and Masuna Srinivasulu, and Michael J Weinstein, and Qingmin Chen, and Rene Alvarez, and Scott A Barros, and Soma De, and Sandra K Klimuk, and Todd Borland, and Verbena Kosovrasti, and William L Cantley, and Ying K Tam, and Muthiah Manoharan, and Marco A Ciufolini, and Mark A Tracy, and Antonin de Fougerolles, and Ian MacLachlan, and Pieter R Cullis, and Thomas D Madden, and Michael J Hope
March 2012, Journal of controlled release : official journal of the Controlled Release Society,
Sean C Semple, and Akin Akinc, and Jianxin Chen, and Ammen P Sandhu, and Barbara L Mui, and Connie K Cho, and Dinah W Y Sah, and Derrick Stebbing, and Erin J Crosley, and Ed Yaworski, and Ismail M Hafez, and J Robert Dorkin, and June Qin, and Kieu Lam, and Kallanthottathil G Rajeev, and Kim F Wong, and Lloyd B Jeffs, and Lubomir Nechev, and Merete L Eisenhardt, and Muthusamy Jayaraman, and Mikameh Kazem, and Martin A Maier, and Masuna Srinivasulu, and Michael J Weinstein, and Qingmin Chen, and Rene Alvarez, and Scott A Barros, and Soma De, and Sandra K Klimuk, and Todd Borland, and Verbena Kosovrasti, and William L Cantley, and Ying K Tam, and Muthiah Manoharan, and Marco A Ciufolini, and Mark A Tracy, and Antonin de Fougerolles, and Ian MacLachlan, and Pieter R Cullis, and Thomas D Madden, and Michael J Hope
November 2013, Journal of controlled release : official journal of the Controlled Release Society,
Sean C Semple, and Akin Akinc, and Jianxin Chen, and Ammen P Sandhu, and Barbara L Mui, and Connie K Cho, and Dinah W Y Sah, and Derrick Stebbing, and Erin J Crosley, and Ed Yaworski, and Ismail M Hafez, and J Robert Dorkin, and June Qin, and Kieu Lam, and Kallanthottathil G Rajeev, and Kim F Wong, and Lloyd B Jeffs, and Lubomir Nechev, and Merete L Eisenhardt, and Muthusamy Jayaraman, and Mikameh Kazem, and Martin A Maier, and Masuna Srinivasulu, and Michael J Weinstein, and Qingmin Chen, and Rene Alvarez, and Scott A Barros, and Soma De, and Sandra K Klimuk, and Todd Borland, and Verbena Kosovrasti, and William L Cantley, and Ying K Tam, and Muthiah Manoharan, and Marco A Ciufolini, and Mark A Tracy, and Antonin de Fougerolles, and Ian MacLachlan, and Pieter R Cullis, and Thomas D Madden, and Michael J Hope
November 2025, ACS applied materials & interfaces,
Sean C Semple, and Akin Akinc, and Jianxin Chen, and Ammen P Sandhu, and Barbara L Mui, and Connie K Cho, and Dinah W Y Sah, and Derrick Stebbing, and Erin J Crosley, and Ed Yaworski, and Ismail M Hafez, and J Robert Dorkin, and June Qin, and Kieu Lam, and Kallanthottathil G Rajeev, and Kim F Wong, and Lloyd B Jeffs, and Lubomir Nechev, and Merete L Eisenhardt, and Muthusamy Jayaraman, and Mikameh Kazem, and Martin A Maier, and Masuna Srinivasulu, and Michael J Weinstein, and Qingmin Chen, and Rene Alvarez, and Scott A Barros, and Soma De, and Sandra K Klimuk, and Todd Borland, and Verbena Kosovrasti, and William L Cantley, and Ying K Tam, and Muthiah Manoharan, and Marco A Ciufolini, and Mark A Tracy, and Antonin de Fougerolles, and Ian MacLachlan, and Pieter R Cullis, and Thomas D Madden, and Michael J Hope
October 2007, Journal of controlled release : official journal of the Controlled Release Society,
Sean C Semple, and Akin Akinc, and Jianxin Chen, and Ammen P Sandhu, and Barbara L Mui, and Connie K Cho, and Dinah W Y Sah, and Derrick Stebbing, and Erin J Crosley, and Ed Yaworski, and Ismail M Hafez, and J Robert Dorkin, and June Qin, and Kieu Lam, and Kallanthottathil G Rajeev, and Kim F Wong, and Lloyd B Jeffs, and Lubomir Nechev, and Merete L Eisenhardt, and Muthusamy Jayaraman, and Mikameh Kazem, and Martin A Maier, and Masuna Srinivasulu, and Michael J Weinstein, and Qingmin Chen, and Rene Alvarez, and Scott A Barros, and Soma De, and Sandra K Klimuk, and Todd Borland, and Verbena Kosovrasti, and William L Cantley, and Ying K Tam, and Muthiah Manoharan, and Marco A Ciufolini, and Mark A Tracy, and Antonin de Fougerolles, and Ian MacLachlan, and Pieter R Cullis, and Thomas D Madden, and Michael J Hope
January 2017, Nanoscale,
Sean C Semple, and Akin Akinc, and Jianxin Chen, and Ammen P Sandhu, and Barbara L Mui, and Connie K Cho, and Dinah W Y Sah, and Derrick Stebbing, and Erin J Crosley, and Ed Yaworski, and Ismail M Hafez, and J Robert Dorkin, and June Qin, and Kieu Lam, and Kallanthottathil G Rajeev, and Kim F Wong, and Lloyd B Jeffs, and Lubomir Nechev, and Merete L Eisenhardt, and Muthusamy Jayaraman, and Mikameh Kazem, and Martin A Maier, and Masuna Srinivasulu, and Michael J Weinstein, and Qingmin Chen, and Rene Alvarez, and Scott A Barros, and Soma De, and Sandra K Klimuk, and Todd Borland, and Verbena Kosovrasti, and William L Cantley, and Ying K Tam, and Muthiah Manoharan, and Marco A Ciufolini, and Mark A Tracy, and Antonin de Fougerolles, and Ian MacLachlan, and Pieter R Cullis, and Thomas D Madden, and Michael J Hope
January 2005, Current pharmaceutical design,
Sean C Semple, and Akin Akinc, and Jianxin Chen, and Ammen P Sandhu, and Barbara L Mui, and Connie K Cho, and Dinah W Y Sah, and Derrick Stebbing, and Erin J Crosley, and Ed Yaworski, and Ismail M Hafez, and J Robert Dorkin, and June Qin, and Kieu Lam, and Kallanthottathil G Rajeev, and Kim F Wong, and Lloyd B Jeffs, and Lubomir Nechev, and Merete L Eisenhardt, and Muthusamy Jayaraman, and Mikameh Kazem, and Martin A Maier, and Masuna Srinivasulu, and Michael J Weinstein, and Qingmin Chen, and Rene Alvarez, and Scott A Barros, and Soma De, and Sandra K Klimuk, and Todd Borland, and Verbena Kosovrasti, and William L Cantley, and Ying K Tam, and Muthiah Manoharan, and Marco A Ciufolini, and Mark A Tracy, and Antonin de Fougerolles, and Ian MacLachlan, and Pieter R Cullis, and Thomas D Madden, and Michael J Hope
May 2011, Journal of controlled release : official journal of the Controlled Release Society,
Sean C Semple, and Akin Akinc, and Jianxin Chen, and Ammen P Sandhu, and Barbara L Mui, and Connie K Cho, and Dinah W Y Sah, and Derrick Stebbing, and Erin J Crosley, and Ed Yaworski, and Ismail M Hafez, and J Robert Dorkin, and June Qin, and Kieu Lam, and Kallanthottathil G Rajeev, and Kim F Wong, and Lloyd B Jeffs, and Lubomir Nechev, and Merete L Eisenhardt, and Muthusamy Jayaraman, and Mikameh Kazem, and Martin A Maier, and Masuna Srinivasulu, and Michael J Weinstein, and Qingmin Chen, and Rene Alvarez, and Scott A Barros, and Soma De, and Sandra K Klimuk, and Todd Borland, and Verbena Kosovrasti, and William L Cantley, and Ying K Tam, and Muthiah Manoharan, and Marco A Ciufolini, and Mark A Tracy, and Antonin de Fougerolles, and Ian MacLachlan, and Pieter R Cullis, and Thomas D Madden, and Michael J Hope
June 2010, Bioconjugate chemistry,
Sean C Semple, and Akin Akinc, and Jianxin Chen, and Ammen P Sandhu, and Barbara L Mui, and Connie K Cho, and Dinah W Y Sah, and Derrick Stebbing, and Erin J Crosley, and Ed Yaworski, and Ismail M Hafez, and J Robert Dorkin, and June Qin, and Kieu Lam, and Kallanthottathil G Rajeev, and Kim F Wong, and Lloyd B Jeffs, and Lubomir Nechev, and Merete L Eisenhardt, and Muthusamy Jayaraman, and Mikameh Kazem, and Martin A Maier, and Masuna Srinivasulu, and Michael J Weinstein, and Qingmin Chen, and Rene Alvarez, and Scott A Barros, and Soma De, and Sandra K Klimuk, and Todd Borland, and Verbena Kosovrasti, and William L Cantley, and Ying K Tam, and Muthiah Manoharan, and Marco A Ciufolini, and Mark A Tracy, and Antonin de Fougerolles, and Ian MacLachlan, and Pieter R Cullis, and Thomas D Madden, and Michael J Hope
January 2022, Evidence-based complementary and alternative medicine : eCAM,
Sean C Semple, and Akin Akinc, and Jianxin Chen, and Ammen P Sandhu, and Barbara L Mui, and Connie K Cho, and Dinah W Y Sah, and Derrick Stebbing, and Erin J Crosley, and Ed Yaworski, and Ismail M Hafez, and J Robert Dorkin, and June Qin, and Kieu Lam, and Kallanthottathil G Rajeev, and Kim F Wong, and Lloyd B Jeffs, and Lubomir Nechev, and Merete L Eisenhardt, and Muthusamy Jayaraman, and Mikameh Kazem, and Martin A Maier, and Masuna Srinivasulu, and Michael J Weinstein, and Qingmin Chen, and Rene Alvarez, and Scott A Barros, and Soma De, and Sandra K Klimuk, and Todd Borland, and Verbena Kosovrasti, and William L Cantley, and Ying K Tam, and Muthiah Manoharan, and Marco A Ciufolini, and Mark A Tracy, and Antonin de Fougerolles, and Ian MacLachlan, and Pieter R Cullis, and Thomas D Madden, and Michael J Hope
January 2023, Evidence-based complementary and alternative medicine : eCAM,
Copied contents to your clipboard!